Research Article Foreign Patients in the Centres of the Italian Association of Paediatric Haematology and Oncology (AIEOP): Data from Registry Mod.1.01
by Roberto Rondelli1*, Riccardo Masetti1, Tamara Belotti1, Franco Locatelli2, Franca Fagioli3, Claudio Favre4, Carlo Dufour5, Alessandra Biffi6, Marco Zecca7, Marco Rabusin8, Maura Massimino9, Andrea Biondi10, Antonio Ruggiero11, Andrea Pession12, Arcangelo Prete1
1Pediatric Oncology and Hematology Unit “Lalla Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
2Department of Hematology Oncology and Transfusion Medicine, IRCCS Pediatric Hospital “Bambino Gesù,” Rome, Italy.
3Paediatric Onco-Haematology Division, Regina Margherita Children’s Hospital, Turin, Italy.
4Department of Pediatric Hematology Oncology, Meyer Children’s Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Florence, Italy.
5Department of Pediatric and Hemato-Oncologic Sciences, IRCCS “Istituto Giannina Gaslini,” Genoa, Italy.
6Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy.
7Pediatric Hematology/Oncology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy.
8Pediatric Hematology-Oncology Unit, Institute for Maternal and Child Health, IRCCS “Burlo Garofolo,” Trieste, Italy.
9Pediatric Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
10 Clinica Pediatrica Universitaria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
11Pediatric Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. 12Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
*Corresponding author: Roberto Rondelli, Pediatric Oncology and Hematology Unit “Lalla Seràgnoli, IRCCS Azienda OspedalieroUniversitaria di Bologna, Bologna, Italy.
Received Date: 14 February, 2024
Accepted Date: 28 February, 2024
Published Date: 04 March, 2024
Citation: Rondelli R, Masetti R, Belotti T, Locatelli F, Fagioli F, et al. (2024) Foreign Patients In The Centres Of The Italian Association Of Paediatric Haematology And Oncology (AIEOP): Data From Registry Mod.1.01. Ann med clin Oncol 7: 160. https://doi.org/10.29011/2833-3497.000160
Abstract
As for children born in Italy, the assistance of foreign children with cancer is assured by the current network of 54 centres of the Italian Association of Paediatric Haematology and Oncology (AIEOP), and since 1989 all data are recorded in the database of AIEOP Mod.1.01 Registry, in this case used to assess the impact of immigration of foreign children with cancer on AIEOP centres’ activity. The information relating to immigrant children, such as their recruitment for years, pathology, age at diagnosis, area of origin, distribution on the Italian territory, and treatment centre, were compared with those cases born and resident in Italy. The male / female ratio is higher for immigrants than for cases born in Italy (1.5 vs. 1.3), conversely the age is lower (7.7 vs. 8.3 years) (p <0.0001).
Approximately 40% of immigrant cases consists of a solid tumour vs. 48% of cases born in Italy (p <0.001). The 20-years survival of immigrants is significantly lower compared to cases born in Italy (p <0.001), both globally (63.9% vs. 77.3%) and for cases with leukaemia or lymphoma (65.0% vs. 84.3%) or solid tumours (62.0% vs. 69.5%). This analysis has demonstrated the effectiveness of Mod.1.01 database as an instrument to measure the phenomenon of immigration of foreign-born children, suffering from cancer, which refer to the network of AIEOP centres, and identify new needs of the paediatric population with cancer in Italy.
Keywords: Paediatric; Haematology; Oncology; Immigration; Foreign.
© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.